AKT1 and cancer: Once activated, the PI3K/AKT pathway becomes the basis of cancer biology and enhances drug efflux by efficiently expressing ABC transporters and reducing the response of chemotherapeutic drugs, which further caused MDR29,30 (Fig. 2).